190 related articles for article (PubMed ID: 37140357)
1. Riluzole and its prodrugs for the treatment of Alzheimer's disease.
Al-Horani RA
Pharm Pat Anal; 2023 Mar; 12(2):79-85. PubMed ID: 37140357
[TBL] [Abstract][Full Text] [Related]
2. Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.
Matthews DC; Mao X; Dowd K; Tsakanikas D; Jiang CS; Meuser C; Andrews RD; Lukic AS; Lee J; Hampilos N; Shafiian N; Sano M; David Mozley P; Fillit H; McEwen BS; Shungu DC; Pereira AC
Brain; 2021 Dec; 144(12):3742-3755. PubMed ID: 34145880
[TBL] [Abstract][Full Text] [Related]
3. Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice.
Hascup KN; Findley CA; Britz J; Esperant-Hilaire N; Broderick SO; Delfino K; Tischkau S; Bartke A; Hascup ER
J Neurochem; 2021 Feb; 156(4):513-523. PubMed ID: 33107040
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal hyperglutamatergic signaling matters: Early targeting glutamate neurotransmission as a preventive strategy in Alzheimer's disease: An Editorial Highlight for "Riluzole attenuates glutamatergic tone and cognitive decline in AβPP/PS1 mice" on page 513.
Gulyaeva NV
J Neurochem; 2021 Feb; 156(4):399-402. PubMed ID: 33276416
[TBL] [Abstract][Full Text] [Related]
5. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway.
Vallée A; Vallée JN; Guillevin R; Lecarpentier Y
Aging (Albany NY); 2020 Feb; 12(3):3095-3113. PubMed ID: 32035419
[TBL] [Abstract][Full Text] [Related]
6. Riluzole rescues alterations in rapid glutamate transients in the hippocampus of rTg4510 mice.
Hunsberger HC; Hickman JE; Reed MN
Metab Brain Dis; 2016 Jun; 31(3):711-5. PubMed ID: 26744018
[TBL] [Abstract][Full Text] [Related]
7. Riluzole ameliorates learning and memory deficits in Aβ25-35-induced rat model of Alzheimer's disease and is independent of cholinoceptor activation.
Mokhtari Z; Baluchnejadmojarad T; Nikbakht F; Mansouri M; Roghani M
Biomed Pharmacother; 2017 Mar; 87():135-144. PubMed ID: 28049095
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Cilostazol Administration in Alzheimer's Disease Patients with White Matter Lesions: A Positron-Emission Tomography Study.
Lee JY; Lee H; Yoo HB; Choi JS; Jung HY; Yoon EJ; Kim H; Jung YH; Lee HY; Kim YK
Neurotherapeutics; 2019 Apr; 16(2):394-403. PubMed ID: 30761509
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect of riluzole in acute noise-induced hearing loss.
Ruel J; Wang J; Pujol R; Hameg A; Dib M; Puel JL
Neuroreport; 2005 Jul; 16(10):1087-90. PubMed ID: 15973153
[TBL] [Abstract][Full Text] [Related]
10. Riluzole, neuroprotection and amyotrophic lateral sclerosis.
Cheah BC; Vucic S; Krishnan AV; Kiernan MC
Curr Med Chem; 2010; 17(18):1942-199. PubMed ID: 20377511
[TBL] [Abstract][Full Text] [Related]
11. Riluzole restores memory and brain energy metabolism in AβPP-PS1 mouse model of Alzheimer's disease.
Saba K; Patel AB
Biochem Biophys Res Commun; 2022 Jun; 610():140-146. PubMed ID: 35462095
[TBL] [Abstract][Full Text] [Related]
12. Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.
Lipton SA
J Alzheimers Dis; 2004 Dec; 6(6 Suppl):S61-74. PubMed ID: 15665416
[TBL] [Abstract][Full Text] [Related]
13. Age and Alzheimer's disease gene expression profiles reversed by the glutamate modulator riluzole.
Pereira AC; Gray JD; Kogan JF; Davidson RL; Rubin TG; Okamoto M; Morrison JH; McEwen BS
Mol Psychiatry; 2017 Feb; 22(2):296-305. PubMed ID: 27021815
[TBL] [Abstract][Full Text] [Related]
14. Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block.
Cifra A; Nani F; Nistri A
Eur J Neurosci; 2011 Mar; 33(5):899-913. PubMed ID: 21324003
[TBL] [Abstract][Full Text] [Related]
15. Glutamatergic regulation prevents hippocampal-dependent age-related cognitive decline through dendritic spine clustering.
Pereira AC; Lambert HK; Grossman YS; Dumitriu D; Waldman R; Jannetty SK; Calakos K; Janssen WG; McEwen BS; Morrison JH
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18733-8. PubMed ID: 25512503
[TBL] [Abstract][Full Text] [Related]
16. Riluzole: what it does to spinal and brainstem neurons and how it does it.
Cifra A; Mazzone GL; Nistri A
Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264
[TBL] [Abstract][Full Text] [Related]
17. Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression.
Hunsberger HC; Weitzner DS; Rudy CC; Hickman JE; Libell EM; Speer RR; Gerhardt GA; Reed MN
J Neurochem; 2015 Oct; 135(2):381-94. PubMed ID: 26146790
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
Verhave PS; Jongsma MJ; Van Den Berg RM; Vanwersch RA; Smit AB; Philippens IH
Neuropharmacology; 2012 Mar; 62(4):1700-7. PubMed ID: 22178201
[TBL] [Abstract][Full Text] [Related]
19. Dementia of Alzheimer's disease and other neurodegenerative disorders--memantine, a new hope.
Sonkusare SK; Kaul CL; Ramarao P
Pharmacol Res; 2005 Jan; 51(1):1-17. PubMed ID: 15519530
[TBL] [Abstract][Full Text] [Related]
20. Is riluzole a new drug for Alzheimer's disease?
Whitcomb DJ; Molnár E
J Neurochem; 2015 Oct; 135(2):207-9. PubMed ID: 26451974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
